Zdrowie i gospodarka · 03/08/2022

FDA Renews Blood Products Advisory Committee for 2 Additional Years

The FDA has renewed the Blood Products Advisory Committee for an additional 2 years, with the new charter set to expire on May 13, 2024, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.